- Home
- ENSC vs ELWS Comparison
ENSC vs ELWS Comparison
Compare ENSC & ELWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- ELWS
- Stock Information
- Founded
- ENSC 2003
- ELWS 2018
- Country
- ENSC United States
- ELWS Japan
- Employees
- ENSC N/A
- ELWS N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- ELWS
- Sector
- ENSC Health Care
- ELWS
- Exchange
- ENSC Nasdaq
- ELWS Nasdaq
- Market Cap
- ENSC 5.5M
- ELWS 6.2M
- IPO Year
- ENSC N/A
- ELWS 2023
- Fundamental
- Price
- ENSC $2.64
- ELWS $2.15
- Analyst Decision
- ENSC
- ELWS
- Analyst Count
- ENSC 0
- ELWS 0
- Target Price
- ENSC N/A
- ELWS N/A
- AVG Volume (30 Days)
- ENSC 24.9K
- ELWS 12.5K
- Earning Date
- ENSC 05-12-2025
- ELWS 03-03-2025
- Dividend Yield
- ENSC N/A
- ELWS N/A
- EPS Growth
- ENSC N/A
- ELWS N/A
- EPS
- ENSC N/A
- ELWS N/A
- Revenue
- ENSC $5,210,031.00
- ELWS $2,292,406.00
- Revenue This Year
- ENSC N/A
- ELWS N/A
- Revenue Next Year
- ENSC N/A
- ELWS N/A
- P/E Ratio
- ENSC N/A
- ELWS N/A
- Revenue Growth
- ENSC 133.58
- ELWS 404.13
- 52 Week Low
- ENSC $2.12
- ELWS $1.04
- 52 Week High
- ENSC $14.67
- ELWS $8.68
- Technical
- Relative Strength Index (RSI)
- ENSC 23.45
- ELWS 44.92
- Support Level
- ENSC $3.30
- ELWS $2.01
- Resistance Level
- ENSC $3.58
- ELWS $2.39
- Average True Range (ATR)
- ENSC 0.32
- ELWS 0.25
- MACD
- ENSC -0.05
- ELWS 0.05
- Stochastic Oscillator
- ENSC 22.21
- ELWS 43.73
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.